Arquivos do dia: Julho 4, 2022

Diretrizes 2022 para o tratamento e a profilaxia do tromboembolismo venoso em pacientes com câncer, incluindo aqueles com COVID-19.

4 Jul, 2022 | 12:24h

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 – The Lancet Oncology

Conteúdos relacionados:

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy – Cochrane Library

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

---

Dois novos estudos mostram que a enoxaparina não tem benefício na tromboprofilaxia primária de pacientes ambulatoriais sintomáticos com COVID-19.

4 Jul, 2022 | 12:23h

Estudo 1: Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet Haematology

Estudo 2: Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial – The Lancet Haematology

Comentários:

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more – The Lancet Haematology

Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter (fio – clique para saber mais)

Early in the pandemic we wondered whether antithrombotic therapy in outpatients with #COVID19 would prevent #thrombosis ❓

Several trials were started globally and the ACTIV-4B trial was previously reported⬇️ https://t.co/Q15WcZwDIA

Now, we publish the OVID and ETHIC trials🧵

— The Lancet Haematology (@TheLancetHaem) June 30, 2022

 

---

Estudo randomizado | Uma dose única e imediata de tenecteplase é não inferior à alteplase para tratar pacientes com AVC isquêmico agudo.

4 Jul, 2022 | 12:21h

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial – The Lancet (link para o resumo – $ para o texto completo)

Comunicado de imprensa: UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke

---

Revisão sistemática | Treinamento para aumentar a mobilidade e a função em idosos frágeis.

4 Jul, 2022 | 12:19h

Mobility training for increasing mobility and functioning in older people with frailty – Cochrane Library

Resumo: Mobility training for increasing mobility and functioning in older people who are frail – Cochrane Library

---

Acurácia do teste rápido de antígeno vs. RT-PCR para infecção por SARS-CoV-2 em atletas universitários durante a prevalência da variante Ômicron.

4 Jul, 2022 | 12:18h

Accuracy of Rapid Antigen vs Reverse Transcriptase–Polymerase Chain Reaction Testing for SARS-CoV-2 Infection in College Athletes During Prevalence of the Omicron Variant – JAMA Network Open

 

Comentário no Twitter

In this case series of college athletes returning to campus during Omicron, rapid antigen tests were 63% sensitive, >99% specific for #COVID19, similar to previous strains and less well in detecting asymptomatic #SARSCoV2. @helixcardinal @stanford_ortho https://t.co/SBPr6NQ9Na

— JAMA Network Open (@JAMANetworkOpen) June 15, 2022

 

---

Estudo de coorte | Efetividade das vacinas Pfizer, Moderna e AstraZeneca contra desfechos graves de Covid-19 em um cenário de vacinação em massa de abrangência nacional.

4 Jul, 2022 | 12:16h

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study – BMJ Medicine

 

Comentário no Twitter

🎉 Read our latest research article comparing the effectiveness of three #COVID vaccines against severe COVID outcomes. ▶️ https://t.co/uaQNgnDrrV#BMJMedicine #MedTwitter #openaccess pic.twitter.com/4oeG5d0j80

— BMJMedicine (@BMJMedicine) June 16, 2022

 

---

Diretriz de consenso | Definição, diagnóstico e manejo clínico da displasia renal não obstrutiva.

4 Jul, 2022 | 12:15h

Definition, diagnosis, and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet working group on Kidney Malformations – Nephrology Dialysis Transplantation

---

Diretriz rápida da UEG e EAES sobre excisão mesorretal total transanal para câncer retal.

4 Jul, 2022 | 12:14h

UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer – Surgical Endoscopy

---

Consenso para definição, classificação, diagnóstico e tratamento da urticária.

4 Jul, 2022 | 12:10h

Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update – Journal of the Formosan Medical Association

---

Orientação ecocardiográfica nas intervenções cardíacas estruturais transcateter.

4 Jul, 2022 | 12:09h

Echocardiographic guidance in transcatheter structural cardiac interventions – EuroIntervention

 

Comentário no Twitter

This richly illustrated State-of-the-Art review focuses on echocardiographic guidance for the most common catheter-based interventions, providing several tips and tricks for practical interventional cardiologists. #EAPCI https://t.co/7bTlMHrzNO pic.twitter.com/l94jms2XK1

— EuroIntervention (@EuroInterventio) February 19, 2022

 

---